Accessory breast

Q17_ACCESSORY_BREAST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q83.1 Cause of death: ICD-10 — Q83.1 2 out of 7 registries used, show all original rules.	248
4. Check minimum number of events None	248
5. Include endpoints None	248
6. Filter based on genotype QC (FinnGen only)	239

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	Q17_ACCESSORY_BREAST
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q831
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q831
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Accessory breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	239	236	-
Unadjusted period prevalence (%)	0.08	0.08	-
Median age at first event (years)	37.56	37.14	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
248: Matched controls
2480

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q83.1

ICD-10 Finland

Accessory breast

+∞

307.7

248

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

+∞

97.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

8.3

31.7

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

7.8

23.6

N62

ICD-10 Finland

Hypertrophy of breast

6.1

18.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.3

15.3

118

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

15.0

13.5

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

4.7

11.1

ZXD10

NOMESCO Finland

Scheduled procedure

2.5

11.0

114

633

ZXA10

NOMESCO Finland

Bilateral

2.8

9.6

226

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.2

8.6

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

8.1

100

583

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

7.5

362

HA1AA

NOMESCO Finland

X-ray mammography

3.1

7.4

117

S04

ICPC

Lump/swelling localized

2.9

7.4

141

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

4.5

7.3

N64.8

ICD-10 Finland

Other specified disorders of breast

16.4

7.3

N63

ICD-10 Finland

Unspecified lump in breast

2.7

6.8

159

Z3226

NOMESCO Finland

Physiotherapist

2.3

6.4

258

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

6.3

385

N64.9

ICD-10 Finland

Disorder of breast, unspecified

8.9

6.1

M03BX02

ATC

tizanidine; oral

2.1

6.1

178

1371

R4110

NOMESCO Finland

Physiotherapy

2.1

6.1

398

N64.4

ICD-10 Finland

Mastodynia

3.6

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

268

2.75

9.90

1.4

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

574

1.89

5.21

2.3

2.2

60.37

55.22

u/l

0.44

542

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

184

1517

1.83

4.14

6.3

6.2

75.44

73.47

u/l

0.31

173

1421

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

139

2.23

3.61

3.1

3.9

4.51

6.34

ug/l

0.28

106

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

631

1.67

3.53

1.9

1.7

—

(40768804) Tissue Pathology biopsy report

121

915

1.63

3.52

2.2

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

238

1.87

3.06

1.3

20.94

27.37

iu/l

0.62

207

(3024561) Albumin [Mass/volume] in Serum or Plasma

688

1.59

3.02

3.5

4.0

36.86

37.09

g/l

0.14

646

(3000850) Epithelial cells [#/volume] in Urine

360

1.72

2.98

2.2

2.4

5.53

11.43

e6/l

1.53

319

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

125

984

1.55

2.88

5.3

4.8

10.41

9.42

umol/l

0.47

117

928

(3022621) pH of Urine by Test strip

131

2.10

2.88

3.0

2.4

—

(3030467) Casts [#/volume] in Urine by Automated count

465

1.64

2.86

3.1

2.5

0.07

0.37

e6/l

2.92

343

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.74

2.67

1.4

1.2

—

(3044889) 12 lead EKG panel

156

1305

1.53

2.61

2.9

2.7

—

(36304419) Bacteria [Presence] in Urine

474

1.57

2.42

3.0

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

285

1.66

2.26

2.1

2.3

2.44

2.42

mmol/l

0.38

250

(3002582) Erythrocytes [#/volume] in Urine

514

1.50

2.11

3.3

2.6

1147.90

51.30

e6/l

0.49

386

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

274

1.64

2.10

1.5

1.7

—

(3026782) Osmolality of Urine

333

1.59

2.09

2.3

2.4

576.38

552.45

mosm/kgh2o

0.37

286

(40768795) Lymph node Pathology biopsy report

4.07

2.05

1.2

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

626

1.46

2.03

2.0

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

228

2130

1.87

1.97

12.0

10.1

17.62

18.80

mg/l

0.21

180

1600

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

470

1.49

1.92

1.7

1.6

0.91

0.71

mg/l

0.35

347

(3023368) Bacteria identified in Blood by Culture

358

1.53

1.89

5.1

3.4

—

(3021589) Normoblasts [#/volume] in Blood

113

928

1.40

1.84

8.1

7.0

0.00

e9/l

0.88

775

(3015377) Calcium [Moles/volume] in Serum or Plasma

602

1.43

1.80

3.4

2.9

2.37

2.35

mmol/l

1.15

554

(40758558) Short blood count panel - Blood

513

1.45

1.77

8.7

6.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

198

1800

1.50

1.77

3.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

470

1.46

1.74

2.0

2.65

2.67

mg/l

0.02

400

(40761536) Microorganisms panel - Urine sediment

197

1.66

1.73

2.9

3.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

584

1.41

1.63

2.9

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

212

1966

1.54

1.60

9.7

8.4

91.84

91.82

ml/min/173m2

0.00

167

1569

(3021788) Differential panel - Synovial fluid

3.05

1.59

1.0

1.9

—

(3044941) Cell count panel - Synovial fluid

3.05

1.59

1.0

1.5

—

(3026008) Bacteria identified in Urine by Culture

579

1.40

1.56

2.3

—

(3018010) Neutrophils/100 leukocytes in Blood

121

1027

1.35

1.53

5.1

4.9

56.31

56.37

0.02

113

967

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

481

1.42

1.53

2.4

2.0

—

(3042936) Bacteria identified in Isolate by Culture

238

1.55

1.50

1.8

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

197

1.59

1.49

2.1

2.4

21.09

24.30

0.61

167

(3029937) Albumin [Presence] in Urine by Test strip

556

1.39

1.49

3.1

3.4

0.00

estimate

0.50

222

(3021879) Hepatitis B virus core Ab [Presence] in Serum

189

1.61

1.48

1.3

1.4

—

(3000494) Fungus identified in Specimen by Culture

223

1.55

1.45

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

688

1.36

1.45

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

3.17

1.44

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.77

1.44

1.5

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

158

1.65

1.44

1.6

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

241

1.53

1.42

3.4

2.2

3.07

4.36

e6/l

0.62

120

(3048689) Calprotectin [Mass/mass] in Stool

327

1.46

1.42

2.0

2.3

105.56

85.58

ug/g

0.28

260

(3052851) Hemolysis interference index of Serum or Plasma

2.22

1.42

2.4

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.85

1.41

1.3

1.2

9.66

13.54

u/l

0.54

(3021601) Nitrite [Presence] in Urine by Test strip

121

1037

1.33

1.40

3.9

4.4

0.00

estimate

0.50

222

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

534

1.38

1.40

2.6

2.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

169

1520

1.35

1.40

3.1

2.7

38.77

36.89

u/l

0.15

160

1457

(3009261) Glucose [Presence] in Urine by Test strip

122

1049

1.32

1.37

3.1

3.2

0.00

estimate

-0.00

213

(3022948) Iron [Moles/volume] in Serum or Plasma

252

1.50

1.36

2.1

2.2

13.76

14.85

umol/l

0.34

234

(40768797) Stomach Pathology biopsy report

261

1.49

1.35

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

446

1.39

1.35

2.5

3.3

1.02

1.01

kg/l

0.28

(3018418) pH of Serum or Plasma

492

1.38

1.33

4.4

3.5

7.40

0.03

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

349

1.43

1.33

1.9

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.84

1.30

2.1

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

218

2054

1.51

1.30

10.8

9.5

3.87

3.90

mmol/l

1.29

212

1990

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

255

1.48

1.29

3.1

2.1

0.64

0.95

e6/l

0.67

135

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.81

1.29

1.2

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

100

1.75

1.27

1.6

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

120

1039

1.30

1.25

3.0

3.2

0.00

estimate

-0.00

232

(3013707) Erythrocyte sedimentation rate by Westergren method

173

1574

1.33

1.24

3.5

3.7

9.34

8.96

mm/h

0.20

162

1473

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

819

1.30

1.21

2.8

3.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

639

1.32

1.21

2.7

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

197

0.54

1.20

9.1

4.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

603

1.32

1.19

1.3

0.52

1.81

u/ml

1.15

172

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

115

999

1.28

1.14

2.5

2.4

—

(1616796) Gas panel - Central venous blood

2.37

1.13

2.3

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

119

1040

1.28

1.11

5.4

5.1

29.59

29.78

0.07

111

985

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.98

1.10

1.3

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.41

1.09

1.2

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.41

1.09

2.0

3.8

29.36

23.90

mu/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

146

1.56

1.07

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

130

1.59

1.06

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

130

1.59

1.06

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.15

1.06

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

106

1.65

1.06

1.3

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

114

997

1.27

1.04

5.5

5.0

2.80

2.72

0.12

105

938

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.30

1.04

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

131

1.57

1.03

1.4

—

(3028300) Cannabinoids [Presence] in Urine

131

1.57

1.03

1.4

—

(3045414) Leukocytes [Presence] in Urine

1.69

1.03

2.7

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

277

1.39

1.01

1.9

2.7

48.94

248.51

ng/l

1.25

142

(3018095) Leukocytes [#/volume] in Urine

654

1.28

1.00

3.8

3.1

58.17

56.53

e6/l

0.01

423

(3019069) Monocytes/100 leukocytes in Blood

114

1001

1.26

1.00

5.8

5.3

7.86

7.80

0.07

105

943

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.98

0.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.98

0.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.98

0.0

1.3

—

(3022096) Basophils/100 leukocytes in Blood

109

954

1.25

0.98

5.4

5.1

0.69

0.70

0.07

100

889

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

694

1.27

0.98

1.6

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

434

1.31

0.95

1.3

20.33

27.43

iu/ml

0.31

154

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

102

1.61

0.93

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

212

1.42

0.91

2.3

1.9

9.71

5.09

umol/l

0.49

180

(3015736) pH of Urine

853

1.25

0.91

2.3

2.9

5.79

5.85

0.11

(40768793) Breast Pathology biopsy report

1.65

0.89

1.1

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

129

1162

1.23

0.86

3.1

2.9

62.68

61.51

ug/l

0.07

123

1111

(3003327) Ova and parasites identified in Stool by Light microscopy

1.63

0.86

1.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.96

0.85

2.5

1.6

5.50

5.01

kpa

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

572

1.26

0.84

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

206

1959

1.30

0.82

3.6

3.5

5.66

5.61

mmol/l

0.25

188

1828

(3000492) Spirometry study

191

1.40

0.81

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

236

1.36

0.79

1.2

1.3

91.15

167.58

iu/ml

0.72

101

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

166

1.42

0.79

2.3

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.79

0.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.76

0.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.76

0.0

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

190

1797

1.25

0.73

4.6

4.4

14.30

14.33

pmol/l

0.05

178

1686

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

187

1766

1.24

0.73

4.5

4.2

37.07

37.73

mmol/mol

0.59

182

1678

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.02

0.73

1.0

1.3

—

(4281824) Cell count and differential, peritoneal fluid

2.02

0.73

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

432

1.26

0.72

1.3

1.2

3.70

8.94

u/ml

0.90

194

(1002224) Polysomnography panel

118

1.47

0.71

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.94

0.71

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

471

1.24

0.70

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

1.62

0.69

2.0

1.7

—

(36660697) Celiac disease serology panel - Serum

197

1.36

0.69

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

206

1.35

0.69

1.2

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.69

0.69

1.1

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.69

0.69

1.0

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

875

1.20

0.68

2.3

71.88

75.88

nmol/l

0.79

810

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.57

0.67

1.5

1.4

0.45

nmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.80

0.66

1.2

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

217

1.33

0.65

1.8

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

155

1446

1.19

0.65

4.3

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

532

1.22

0.65

1.4

1.3

2.34

2.04

g/l

0.66

337

(3016879) Cocaine [Presence] in Urine

121

1.43

0.64

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1.74

0.64

1.8

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

104

1.47

0.64

1.1

2.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

112

1017

1.18

0.64

3.7

5.87

6.25

mmol/l

3.19

103

907

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

572

1.21

0.62

2.8

2.7

13.02

19.17

ng/l

1.34

269

(40761511) CBC panel - Blood by Automated count

233

2271

1.43

0.62

11.0

9.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.68

0.61

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

366

1.25

0.61

1.3

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

24.99

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.60

0.0

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

1.13

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.55

0.60

2.1

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

161

0.67

0.59

1.6

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

229

2229

1.36

0.58

9.7

8.3

25.41

23.46

u/l

0.84

224

2173

(3022217) INR in Platelet poor plasma by Coagulation assay

643

1.19

0.58

9.4

6.1

1.11

1.06

inr

0.30

227

(3006315) Basophils [#/volume] in Blood

115

1053

1.17

0.58

5.6

5.0

0.04

e9/l

0.39

943

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1.73

0.58

1.0

1.1

—

148.10

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

132

1223

1.17

0.57

9.7

8.0

3.79

3.90

e9/l

0.28

114

1074

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

168

1.34

0.57

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

1.68

0.57

1.5

1.6

—

(3011288) Drugs identified in Urine by Screen method

1.47

0.56

1.4

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

119

1095

1.17

0.56

5.5

5.0

1.94

2.06

e9/l

0.43

104

1007

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.64

0.56

1.5

1.6

0.95

0.98

nmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.45

0.54

1.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

1.55

0.53

1.2

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

326

1.23

0.53

1.4

1.5

—

(40768443) Skin Pathology biopsy report

1.49

0.51

1.2

—

(3001604) Monocytes [#/volume] in Blood

114

1052

1.15

0.50

5.5

5.0

0.53

0.51

e9/l

0.32

945

(1001926) Buprenorphine [Presence] in Urine by Screen method

101

1.41

0.50

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.54

0.48

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

213

2065

1.22

0.48

5.3

5.0

1.55

2.26

mu/l

0.68

199

1953

(3019060) Gas panel - Arterial blood

1.49

0.47

3.5

5.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.47

0.47

1.0

2.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.47

0.47

1.0

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

331

1.21

0.46

1.4

1.3

805.71

517.92

titre

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

455

1.18

0.45

2.1

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

1.38

0.44

5.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

203

1.26

0.44

2.6

2.1

10904.36

4322.58

u/l

0.32

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

717

1.15

0.43

5.1

4.7

1.22

mmol/l

0.13

656

(3027315) Oxygen [Partial pressure] in Blood

1.63

0.43

2.8

1.6

9.04

9.59

kpa

—

(3013115) Eosinophils [#/volume] in Blood

118

1102

1.14

0.42

6.4

5.5

0.19

0.17

e9/l

0.40

103

998

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.57

0.42

1.0

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.57

0.42

1.0

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

108

1004

1.13

0.41

5.3

5.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.41

0.41

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

22.64

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

383

1.18

0.41

1.3

1.4

22.80

20.29

nmol/l

0.63

335

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.41

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.40

0.0

2.4

—

4.03

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.40

0.0

2.4

—

106.11

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.40

0.0

2.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.43

0.40

1.1

1.2

4.86

3.15

ug/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

142

1.29

0.40

1.6

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

318

1.19

0.40

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.39

0.0

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

157

0.75

0.37

1.1

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

144

1.27

0.36

1.1

—

106.00

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

190

1.23

0.36

3.0

3.4

28.53

33.10

1.31

131

(3025941) Bacteria identified in Stool by Culture

128

1.27

0.33

1.4

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

307

1.16

0.31

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

106

0.75

0.29

2.5

2.1

67.39

67.95

g/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.33

0.28

3.6

4.2

25.61

24.76

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

874

1.10

0.28

2.1

2.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.30

0.28

6.0

7.2

95.66

94.03

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

300

1.15

0.28

2.0

2.5

669.01

870.12

ng/l

0.19

244

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.26

0.27

5.6

7.0

0.88

0.73

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.26

0.27

5.6

7.0

1.60

1.27

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.26

0.26

1.1

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

295

1.14

0.23

1.3

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

812

1.09

0.23

5.5

5.3

1.22

mmol/l

0.04

686

(3018405) Lactate [Moles/volume] in Arterial blood

1.29

0.23

5.0

3.9

0.96

1.30

mmol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

6.71

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

0.53

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

10.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

28.11

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

83.89

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.21

0.0

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.21

0.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

25.77

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.1

—

0.66

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

521

1.10

0.21

1.5

1.6

1.44

1.36

mmol/l

0.34

456

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.21

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.26

0.20

3.8

1.8

12.70

13.33

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.20

0.0

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.20

0.0

1.1

—

32.36

—

(3012516) Albumin [Mass/volume] in Urine

383

0.90

0.19

2.0

3.1

1551.65

578.24

mg/l

0.27

247

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.16

0.19

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.19

1.8

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

143

0.83

0.19

1.9

2.2

85.83

81.02

ml/min/173m2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.16

0.16

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

206

1.13

0.16

1.3

1.5

—

(3022145) Colonoscopy Study observation

214

0.88

0.16

1.5

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

178

1.13

0.15

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

178

1.13

0.15

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

0.74

0.15

1.3

2.1

3.10

4.15

ug/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

204

2011

1.08

0.15

3.4

3.5

1.56

mmol/l

0.04

196

1903

(3003694) ABO and Rh group [Type] in Blood

737

1.06

0.15

1.8

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

1.19

0.14

1.4

2.4

61.33

77.91

e9/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

179

1.13

0.14

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

179

1.13

0.14

1.4

—

(4200892) Spirometry reversibility

122

1.16

0.14

1.2

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

472

1.07

0.14

1.7

2.8

8.85

7.71

mmol/l

0.71

418

(21494755) Public health laboratory ask at order entry panel

306

1.09

0.13

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

405

0.93

0.13

2.3

3.7

2.41

9.03

mg/mmol

1.91

244

(3023511) Choriogonadotropin [Units/volume] in Urine

123

1.15

0.13

1.6

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

123

1.15

0.13

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

147

0.88

0.12

2.3

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

147

0.88

0.12

2.5

1.6

—

(3000991) Gas panel - Venous blood

1.17

0.11

5.3

6.1

—

(3008898) HLA-B27 [Presence]

144

1.12

0.10

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

448

1.06

0.10

2.9

3.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.11

0.10

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.09

0.09

1.0

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.07

0.09

1.2

1.6

1.02

6.86

ug/l

—

(40761535) Cells panel - Urine sediment

124

0.88

0.09

2.8

3.2

—

(3005033) Fetal Nuchal fold Thickness US

146

1.10

0.08

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

147

1.09

0.07

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.03

0.07

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

1.06

0.07

4.0

2.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

204

2023

1.05

0.07

3.5

4.85

mmol/l

0.03

198

1921

(3014576) Chloride [Moles/volume] in Serum or Plasma

141

0.92

0.05

4.1

5.2

105.77

105.01

mmol/l

0.36

141

(3019225) pH of Specimen

151

0.92

0.05

3.7

—

(4035726) Immunohistochemistry procedure

149

1.08

0.05

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

150

1.07

0.04

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

194

1930

1.02

0.02

3.2

1.26

1.19

mmol/l

0.77

186

1813

(3018677) aPTT in Platelet poor plasma by Coagulation assay

206

0.97

0.00

1.6

1.7

27.86

29.51

1.25

199

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

139

1.01

0.00

1.4

241.85

276.20

miu/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

161

0.99

0.00

3.6

2.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

231

1.00

0.00

2.3

1.7

—

(3013512) EKG study

421

1.00

0.00

2.9

2.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

205

2049

1.00

0.00

3.9

3.8

2.88

2.91

mmol/l

0.25

197

1933

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

671

1.00

0.00

1.6

1.8

99.11

97.44

pmol/l

0.10

350

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

217

1.02

0.00

1.1

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.97

0.00

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(40768446) Kidney Pathology biopsy report

0.00

-0.00

0.0

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

11.20

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.94

-0.00

1.0

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

7.6

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.92

-0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.0

—

12.68

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.93

-0.00

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.99

-0.00

2.1

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

2.52

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

33.67

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.8

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.00

-0.00

0.0

34.0

—

5.92

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.94

-0.00

1.3

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.98

-0.00

1.2

—

40.57

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.5

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

190

1.00

-0.00

1.7

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.00

-0.00

1.6

1.9

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

7.18

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.91

-0.00

1.8

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

2.3

2.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

2.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.91

-0.00

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.91

-0.00

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

2.2

—

47.40

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.0

—

277.17

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.96

-0.00

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_ACCESSORY_BREAST – Accessory breast

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Accessory breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Accessory breast (Q17_ACCESSORY_BREAST)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints